HY-100786-50mg
|
MedChemexpress LLC
|
DL-AP3 [CAS 5652-28-8]
|
|
Cancer-programmed cell death
|
|
HY-10082-10mg
|
MedChemexpress LLC
|
Triapine [CAS 143621-35-6]
|
|
Cancer-programmed cell death
|
|
HY-10082-25mg
|
MedChemexpress LLC
|
Triapine [CAS 143621-35-6]
|
|
Cancer-programmed cell death
|
|
HY-10082-5mg
|
MedChemexpress LLC
|
Triapine [CAS 143621-35-6]
|
|
Cancer-programmed cell death
|
|
HY-10082-50mg
|
MedChemexpress LLC
|
Triapine [CAS 143621-35-6]
|
|
Cancer-programmed cell death
|
|
HY-101180-1mg
|
MedChemexpress LLC
|
C2 Ceramide [CAS 3102-57-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-101180-5mg
|
MedChemexpress LLC
|
C2 Ceramide [CAS 3102-57-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-101510-10mg
|
MedChemexpress LLC
|
F1063-0967 [CAS 613225-56-2]
|
|
Cancer-programmed cell death
|
|
HY-101510-100mg
|
MedChemexpress LLC
|
F1063-0967 [CAS 613225-56-2]
|
|
Cancer-programmed cell death
|
|
HY-101510-5mg
|
MedChemexpress LLC
|
F1063-0967 [CAS 613225-56-2]
|
|
Cancer-programmed cell death
|
|
HY-101510-50mg
|
MedChemexpress LLC
|
F1063-0967 [CAS 613225-56-2]
|
|
Cancer-programmed cell death
|
|
HY-101964-10mg
|
MedChemexpress LLC
|
SPI-112 [CAS 1051387-90-6]
|
|
Cancer-programmed cell death
|
|
HY-101964-25mg
|
MedChemexpress LLC
|
SPI-112 [CAS 1051387-90-6]
|
|
Cancer-programmed cell death
|
|
HY-101964-5mg
|
MedChemexpress LLC
|
SPI-112 [CAS 1051387-90-6]
|
|
Cancer-programmed cell death
|
|
HY-101964-50mg
|
MedChemexpress LLC
|
SPI-112 [CAS 1051387-90-6]
|
|
Cancer-programmed cell death
|
|
HY-103241-10mg
|
MedChemexpress LLC
|
Ro 90-7501 [CAS 293762-45-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-103241-100mg
|
MedChemexpress LLC
|
Ro 90-7501 [CAS 293762-45-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-103241-25mg
|
MedChemexpress LLC
|
Ro 90-7501 [CAS 293762-45-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-103241-5mg
|
MedChemexpress LLC
|
Ro 90-7501 [CAS 293762-45-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-103241-50mg
|
MedChemexpress LLC
|
Ro 90-7501 [CAS 293762-45-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-103701A-100mg
|
MedChemexpress LLC
|
L-Ascorbic acid 2-phosphate (magnesium) [CAS 113170-55-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-103701A-500mg
|
MedChemexpress LLC
|
L-Ascorbic acid 2-phosphate (magnesium) [CAS 113170-55-1]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-106064A-1mg
|
MedChemexpress LLC
|
Piriprost (potassium) [CAS 88851-62-1]
|
|
|
|
HY-106961-10mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-106961-100mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|